Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that its Surgical Devices business unit has received FDA 510(k) clearance to market the Covidien SILS? Procedure Kit, indicated for Single-Incision Laparoscopic Surgery and other advanced laparoscopic procedures.

More: continued here

This entry was posted on Thursday, May 22nd, 2008 at 10:05 am and is filed under GastroIntestinal / Gastroentorology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.